FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2–induced resistance
Westover, D., Ling, X., Lam, H., Welch, J., Jin, C., Gongora, C., Del Rio, M., Wani, M., & Li, F. (2015). FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2–induced resistance. Molecular Cancer, 14(92), 1 - 11.
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.